6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide (BioDeep_00000175151)

   

human metabolite blood metabolite


代谢物信息卡片


6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide

化学式: C21H25N3O2 (351.194667)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CNC(=O)C1=CN=C(C=C1)OC2=CC3=C(CCN(CC3)C4CCC4)C=C2
InChI: InChI=1S/C21H25N3O2/c1-22-21(25)17-6-8-20(23-14-17)26-19-7-5-15-9-11-24(18-3-2-4-18)12-10-16(15)13-19/h5-8,13-14,18H,2-4,9-12H2,1H3,(H,22,25)

描述信息

GSK189254A (GSK189254 free base) is a novel, potent and selective histamine H3 receptor antagonist with pKi values of 9.59-9.90 and 8.51-9.17 for human and rat H3, respectively.

同义名列表

5 个代谢物同义名

6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide; 6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide; 6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide; GSK189254 (free base); GSK189254A



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Nafiseh Ghazanfari, Aren van Waarde, Janine Doorduin, Jürgen W A Sijbesma, Maria Kominia, Martin Koelewijn, Khaled Attia, Antoon T M Willemsen, Ton J Visser, André Heeres, Rudi A J O Dierckx, Erik F J de Vries, Philip H Elsinga. Pharmacokinetic Modeling of [11C]GSK-189254, PET Tracer Targeting H3 Receptors, in Rat Brain. Molecular pharmaceutics. 2022 03; 19(3):918-928. doi: 10.1021/acs.molpharmaceut.1c00889. [PMID: 35170965]
  • Daniel S Whittaker, Huei-Bin Wang, Dawn H Loh, Roger Cachope, Christopher S Colwell. Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease. Pharmacology research & perspectives. 2017 10; 5(5):. doi: 10.1002/prp2.344. [PMID: 28971617]
  • Jean-Dominique Gallezot, Beata Planeta, Nabeel Nabulsi, Donna Palumbo, Xiaoxi Li, Jing Liu, Carolyn Rowinski, Kristin Chidsey, David Labaree, Jim Ropchan, Shu-Fei Lin, Aarti Sawant-Basak, Timothy J McCarthy, Anne W Schmidt, Yiyun Huang, Richard E Carson. Determination of receptor occupancy in the presence of mass dose: [11C]GSK189254 PET imaging of histamine H3 receptor occupancy by PF-03654746. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2017 Mar; 37(3):1095-1107. doi: 10.1177/0271678x16650697. [PMID: 27207170]
  • Eleonora Veglia, Cristina Grange, Alessandro Pini, Aldo Moggio, Cecilia Lanzi, Giovanni Camussi, Paul L Chazot, Arianna Carolina Rosa. Histamine receptor expression in human renal tubules: a comparative pharmacological evaluation. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 2015 Apr; 64(3-4):261-70. doi: 10.1007/s00011-015-0807-z. [PMID: 25725698]
  • S Ashworth, A Berges, E A Rabiner, A A Wilson, R A Comley, R Y K Lai, R Boardley, G Searle, R N Gunn, M Laruelle, V J Cunningham. Unexpectedly high affinity of a novel histamine H(3) receptor antagonist, GSK239512, in vivo in human brain, determined using PET. British journal of pharmacology. 2014 Mar; 171(5):1241-9. doi: 10.1111/bph.12505. [PMID: 24670146]
  • Aurelija Jucaite, Akihiro Takano, Emma Boström, Karl-Gustav Jostell, Per Stenkrona, Christer Halldin, Märta Segerdahl, Svante Nyberg. AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects. The international journal of neuropsychopharmacology. 2013 Jul; 16(6):1231-9. doi: 10.1017/s1461145712001411. [PMID: 23217964]
  • Cristian Salinas, David Weinzimmer, Graham Searle, David Labaree, Jim Ropchan, Yiyun Huang, Eugenii A Rabiner, Richard E Carson, Roger N Gunn. Kinetic analysis of drug-target interactions with PET for characterization of pharmacological hysteresis. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2013 May; 33(5):700-7. doi: 10.1038/jcbfm.2012.208. [PMID: 23385202]
  • Jean Logan, Nicholas I Carruthers, Michael A Letavic, Steven Sands, Xiaohui Jiang, Colleen Shea, Lisa Muench, Youwen Xu, Pauline Carter, Payton King, Joanna S Fowler. Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboon. Psychopharmacology. 2012 Oct; 223(4):447-55. doi: 10.1007/s00213-012-2733-x. [PMID: 22614669]
  • Robert L Hudkins, Rita Raddatz, Ming Tao, Joanne R Mathiasen, Lisa D Aimone, Nadine C Becknell, Catherine P Prouty, Lars J S Knutsen, Mehran Yazdanian, Gilbert Moachon, Mark A Ator, John P Mallamo, Michael J Marino, Edward R Bacon, Michael Williams. Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist. Journal of medicinal chemistry. 2011 Jul; 54(13):4781-92. doi: 10.1021/jm200401v. [PMID: 21634396]
  • Robert J Altenbach, Lawrence A Black, Marina I Strakhova, Arlene M Manelli, Tracy L Carr, Kennan C Marsh, Jill M Wetter, Erica J Wensink, Gin C Hsieh, Prisca Honore, Tiffany Runyan Garrison, Jorge D Brioni, Marlon D Cowart. Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain. Journal of medicinal chemistry. 2010 Nov; 53(21):7869-73. doi: 10.1021/jm100666w. [PMID: 20945906]
  • Sharon Ashworth, Eugenii A Rabiner, Roger N Gunn, Christophe Plisson, Alan A Wilson, Robert A Comley, Robert Y K Lai, Antony D Gee, Marc Laruelle, Vincent J Cunningham. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010 Jul; 51(7):1021-9. doi: 10.2967/jnumed.109.071753. [PMID: 20554726]